1 |
(2)-epigallocatechin-3-gallate (egcg) |
Epigallocatechin |
- |
- |
- |
008 [1] 8 💬 |
2 |
20 mg ga |
- |
- |
- |
- |
013 [1] 13 💬 |
3 |
20mg/0.5ml ga |
- |
- |
- |
- |
013 [1] 13 💬 |
4 |
40 mg ga |
- |
- |
- |
- |
002 [2] 2 , 13 💬 |
5 |
Aav1-gamma-sarcoglycan vector injection |
- |
- |
- |
- |
113 [1] 113 💬 |
6 |
Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase a cdna |
Agalsidase alfa |
[1] D02784 D02784 💬 |
GLA [1] GLA 💬 |
Galactose metabolism [6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 [1] 19 💬 |
7 |
Administration of drug (interferon-gamma 1-b) subcutaneously |
- |
- |
- |
- |
065 [1] 65 💬 |
8 |
Adverse reactions of gammagard subcutaneously at week 12 |
- |
- |
- |
- |
065 [1] 65 💬 |
9 |
Adverse reactions of gammagard subcutaneously at week 24 |
- |
- |
- |
- |
065 [1] 65 💬 |
10 |
Adverse reactions of gammagard subcutaneously at week 36 |
- |
- |
- |
- |
065 [1] 65 💬 |
11 |
Adverse reactions of gammagard subdermally at week 12 |
- |
- |
- |
- |
065 [1] 65 💬 |
12 |
Adverse reactions of gammagard subdermally at week 24 |
- |
- |
- |
- |
065 [1] 65 💬 |
13 |
Adverse reactions of gammagard subdermally at week 36 |
- |
- |
- |
- |
065 [1] 65 💬 |
14 |
Aerosol interferon-gamma |
- |
- |
- |
- |
085 [1] 85 💬 |
15 |
Aert, (r)-baclofen |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
16 |
Alpha-galactosidase a |
Agalsidase alfa |
[1] D02784 D02784 💬 |
GLA [1] GLA 💬 |
Galactose metabolism [6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 [1] 19 💬 |
17 |
Analysis of gamma globulin |
- |
- |
- |
- |
084 [1] 84 💬 |
18 |
Anti-interferon-gamma monoclonal antibody |
- |
- |
- |
- |
096 [1] 96 💬 |
19 |
Anti-pseudomonas igy gargle |
- |
- |
- |
- |
299 [1] 299 💬 |
20 |
Antithymocyte gamma immunoglobulin |
- |
- |
- |
- |
013 [1] 13 💬 |
21 |
Baclofen |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
002 [5] 2 , 10, 13, 18, 149 💬 |
22 |
Baclofen 20 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
23 |
Baclofen er capsules (grs) 10 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
24 |
Baclofen er capsules (grs) 20 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
25 |
Baclofen er capsules (grs) 30mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
26 |
Baclofen er capsules (grs) 40mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
27 |
Baclofen er capsules (grs) 50 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
28 |
Baclofen ir |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
29 |
Baclofen tablets usp |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
30 |
Baclofen tablets usp 10 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
31 |
Behavioral: gait and balance |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
32 |
Behavioral: gait and balance training program |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
33 |
Bitterschleifenblume-ganzpflanze 1,5ml/10ml |
- |
- |
- |
- |
097 [1] 97 💬 |
34 |
Boots high strength garlic odour controlled |
Garlic |
- |
- |
- |
299 [1] 299 💬 |
35 |
Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
070 [1] 70 💬 |
36 |
Budenofalk 3mg gastro-resistant capsules |
- |
- |
- |
- |
096 [1] 96 💬 |
37 |
Budenofalk 9mg gastro-resistant granules |
- |
- |
- |
- |
096 [1] 96 💬 |
38 |
Coconut oil and epigallocatechin gallate |
Coconut |
[1] D05326 D05326 💬 |
- |
- |
013 [1] 13 💬 |
39 |
D-galactose |
Galactose |
[1] D04291 D04291 💬 |
- |
- |
222 [1] 222 💬 |
40 |
Device: chrono super pid then generic syringe-gammanorm |
- |
- |
- |
- |
065 [1] 65 💬 |
41 |
Device: cotton gauze with petrolatum |
Cotton |
[2] D05304 D05304, D05331 D05331 💬 |
- |
- |
035 [2] 35, 162 💬 |
42 |
Device: generic syringe then chrono super pid-gammanorm |
- |
- |
- |
- |
065 [1] 65 💬 |
43 |
Device: magnetic resonance imaging (mri) with gadolinium enhancement |
Gadolinium |
- |
- |
- |
058 [1] 58 💬 |
44 |
Device: magnetic resonance imaging (mri) without gadolinium enhancement |
Gadolinium |
- |
- |
- |
058 [1] 58 💬 |
45 |
Device: percutaneous endoscopic gastrostomy tube |
- |
- |
- |
- |
006 [1] 6 💬 |
46 |
Device: percutaneous endoscopic gastrostomy tube (peg tube) |
- |
- |
- |
- |
006 [1] 6 💬 |
47 |
Device: video game therapy |
- |
- |
- |
- |
013 [1] 13 💬 |
48 |
Diagnostic test: 68-ga ha-dotatate pet/ct |
Dotatate |
- |
- |
- |
041 [1] 41 💬 |
49 |
Diagnostic test: cardiac mri (gadolinium enhanced) |
Gadolinium |
- |
- |
- |
086 [1] 86 💬 |
50 |
Diagnostic test: gait analysis |
- |
- |
- |
- |
149 [1] 149 💬 |
51 |
Efficacy of gammagard subcutaneously at week 12 |
- |
- |
- |
- |
065 [1] 65 💬 |
52 |
Efficacy of gammagard subcutaneously at week 24 |
- |
- |
- |
- |
065 [1] 65 💬 |
53 |
Efficacy of gammagard subcutaneously at week 36 |
- |
- |
- |
- |
065 [1] 65 💬 |
54 |
Efficacy of gammagard subdermally at week 12 |
- |
- |
- |
- |
065 [1] 65 💬 |
55 |
Efficacy of gammagard subdermally at week 24 |
- |
- |
- |
- |
065 [1] 65 💬 |
56 |
Efficacy of gammagard subdermally at week 36 |
- |
- |
- |
- |
065 [1] 65 💬 |
57 |
Emapalumab |
Emapalumab |
[1] D11120 D11120 💬 |
IFNG [1] IFNG 💬 |
African trypanosomiasis [32] African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
107 [1] 107 💬 |
58 |
Encapsulated baclofen 20 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
59 |
Epigallocatechin gallate |
Epigallocatechin |
- |
- |
- |
013 [1] 13 💬 |
60 |
Epigallocatechin-3-gallate (egcg) |
Epigallocatechin |
- |
- |
- |
028 [2] 28, 85 💬 |
61 |
Epigallocatechin-gallate |
Epigallocatechin |
- |
- |
- |
113 [1] 113 💬 |
62 |
Epigallocatechin-gallate (sunphenon) |
Epigallocatechin |
- |
- |
- |
013 [1] 13 💬 |
63 |
Ex-vivo expanded autologous human keratinocytes suspension containing epidermal stem cells genetically modified with a gamma-retroviral (rv) vector expressing the full-length lamb3 cdna. |
- |
- |
- |
- |
036 [1] 36 💬 |
64 |
Firategrast gastro-retentive solution |
Firategrast |
[1] D06590 D06590 💬 |
ITGA4 [1] ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy [14] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 [1] 13 💬 |
65 |
Fish oil, gamma-linolenic acid |
Fish oil |
[1] D07213 D07213 💬 |
- |
- |
046 [1] 46 💬 |
66 |
Fully human anti-interferon gamma monoclonal antibody |
Interferon Gamma |
- |
- |
- |
107 [1] 107 💬 |
67 |
Ga |
- |
- |
- |
- |
013 [1] 13 💬 |
68 |
Ga 20 mg/ml |
- |
- |
- |
- |
013 [1] 13 💬 |
69 |
Ga 40 mg/ml |
- |
- |
- |
- |
013 [1] 13 💬 |
70 |
Ga depot |
- |
- |
- |
- |
013 [1] 13 💬 |
71 |
Ga depot 40 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
72 |
Ga depot 40mg once monthly |
- |
- |
- |
- |
013 [1] 13 💬 |
73 |
Ga depot 80 mg |
- |
- |
- |
- |
013 [1] 13 💬 |
74 |
Ga-68-dota-noc |
- |
- |
- |
- |
084 [1] 84 💬 |
75 |
Ga-gcb |
Velaglucerase alfa |
[1] D09029 D09029 💬 |
GBA [1] GBA 💬 |
Lysosome [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 [1] 19 💬 |
76 |
Ga-gcb (velaglucerase alfa) |
Velaglucerase alfa |
[1] D09029 D09029 💬 |
GBA [1] GBA 💬 |
Lysosome [4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism |
019 [1] 19 💬 |
77 |
Gabapentin |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 [5] 6 , 13, 19, 70, 298 💬 |
78 |
Gabapentin prescriptions |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
298 [1] 298 💬 |
79 |
Gabapentina |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 [1] 6 💬 |
80 |
Gabapentina kern pharma |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 [1] 6 💬 |
81 |
Gabapentine |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
013 [1] 13 💬 |
82 |
Gabapentine 300mg |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
013 [1] 13 💬 |
83 |
Gaboxadol |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [2] 201, 206 💬 |
84 |
Gaboxadol monohydrate |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
85 |
Gaboxadol monohydrate 0.5 mg |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
86 |
Gaboxadol monohydrate 0.5 mg (intended commercial formulation) |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
87 |
Gaboxadol monohydrate 0.5 mg capsule |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
88 |
Gaboxadol monohydrate 2 mg |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
89 |
Gaboxadol monohydrate 2 mg (intended commercial formulation) |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
90 |
Gaboxadol monohydrate 2 mg capsule |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
91 |
Gaboxadol monohydrate 5 mg |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
92 |
Gaboxadol monohydrate 5 mg (intended commercial formulation) |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
93 |
Gadobenate |
Gadobenic acid |
[2] D04283 D04283, D08018 D08018 💬 |
- |
- |
013 [1] 13 💬 |
94 |
Gadobenate dimeglumine |
Gadobenic acid |
[2] D04283 D04283, D08018 D08018 💬 |
- |
- |
013 [1] 13 💬 |
95 |
Gadobutrol |
Gadobutrol |
[1] D07420 D07420 💬 |
- |
- |
013 [3] 13, 22, 46 💬 |
96 |
Gadodiamide |
Gadodiamide |
[2] D01645 D01645, D04284 D04284 💬 |
- |
- |
305 [1] 305 💬 |
97 |
Gadolinium |
Gadolinium |
- |
- |
- |
013 [6] 13, 34, 46, 58, 65, 86 💬 |
98 |
Gadolinium contrast |
Gadolinium |
- |
- |
- |
034 [1] 34 💬 |
99 |
Gadolinium for abdomen |
Gadolinium |
- |
- |
- |
065 [1] 65 💬 |
100 |
Gadolinium for lower back |
Gadolinium |
- |
- |
- |
065 [1] 65 💬 |
101 |
Gadolinium-based contrast |
Gadolinium |
- |
- |
- |
013 [1] 13 💬 |
102 |
Gadopentetate |
Gadopentetic acid |
[2] D01707 D01707, D08006 D08006 💬 |
- |
- |
013 [2] 13, 34 💬 |
103 |
Gadoterate |
Gadoteric acid |
[1] D08007 D08007 💬 |
- |
- |
053 [1] 53 💬 |
104 |
Gadoteric acid |
Gadoteric acid |
[1] D08007 D08007 💬 |
- |
- |
013 [1] 13 💬 |
105 |
Gadoteridol |
Gadoteridol |
[1] D01137 D01137 💬 |
- |
- |
013 [1] 13 💬 |
106 |
Gadovist |
- |
- |
- |
- |
013 [2] 13, 22 💬 |
107 |
Gadovist 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado |
- |
- |
- |
- |
013 [1] 13 💬 |
108 |
Gadovist 1.0 mmol/ml injektionslösung |
- |
- |
- |
- |
013 [1] 13 💬 |
109 |
Galactose |
Galactose |
[1] D04291 D04291 💬 |
- |
- |
171 [2] 171, 222 💬 |
110 |
Galafold |
- |
- |
- |
- |
019 [1] 19 💬 |
111 |
Galantamine |
Galantamine |
[2] D02173 D02173, D04292 D04292 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [2] 6 , 127 💬 |
112 |
Galantamine hydrobromide |
Galantamine |
[2] D02173 D02173, D04292 D04292 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
127 [1] 127 💬 |
113 |
Galen® tablet |
- |
- |
- |
- |
043 [2] 43, 44 💬 |
114 |
Galicaftor |
Galicaftor |
[1] D11724 D11724 💬 |
CFTR [1] CFTR 💬 |
ABC transporters [8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway |
299 [1] 299 💬 |
115 |
Gallium nitrate |
Gallium nitrate |
[2] D00940 D00940, D02313 D02313 💬 |
- |
- |
299 [1] 299 💬 |
116 |
Gallium-68 dotatate |
Dotatate |
- |
- |
- |
084 [1] 84 💬 |
117 |
Gallium-68-dota-n-octreotide |
Octreotide |
[2] D00442 D00442, D06495 D06495 💬 |
SSTR2 [1] SSTR2 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
084 [1] 84 💬 |
118 |
Gallium68-dota-noc |
- |
- |
- |
- |
085 [1] 85 💬 |
119 |
Galsulfase |
Galsulfase |
[1] D06565 D06565 💬 |
ARSB [1] ARSB 💬 |
Glycosaminoglycan degradation [3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 [1] 19 💬 |
120 |
Gamma globulin |
- |
- |
- |
- |
015 [2] 15, 50 💬 |
121 |
Gamma interferon |
- |
- |
- |
- |
018 [1] 18 💬 |
122 |
Gamma-linolenic acid |
Gamolenic acid |
[1] D07213 D07213 💬 |
- |
- |
046 [1] 46 💬 |
123 |
Gamma-secretase/notch signalling pathway inhibitor ro4929097 |
- |
- |
- |
- |
074 [1] 74 💬 |
124 |
Gamma-tocopherol |
Tocopherol |
[1] D02332 D02332 💬 |
- |
- |
013 [1] 13 💬 |
125 |
Gammagard liquid |
- |
- |
- |
- |
065 [1] 65 💬 |
126 |
Gammagard s/d (solvent/detergent) |
- |
- |
- |
- |
065 [1] 65 💬 |
127 |
Gammaglobulin |
- |
- |
- |
- |
065 [1] 65 💬 |
128 |
Gammanorm |
- |
- |
- |
- |
014 [2] 14, 65 💬 |
129 |
Gammanorm 165 mg/ml |
- |
- |
- |
- |
065 [1] 65 💬 |
130 |
Gammaplex |
- |
- |
- |
- |
063 [2] 63, 65 💬 |
131 |
Gammaplex (5%) |
- |
- |
- |
- |
065 [1] 65 💬 |
132 |
Gammaplex (intravenous immunoglobulin) |
- |
- |
- |
- |
065 [1] 65 💬 |
133 |
Gammaplex 10 |
- |
- |
- |
- |
065 [1] 65 💬 |
134 |
Gammaplex, intravenous immunoglobulin |
- |
- |
- |
- |
063 [1] 63 💬 |
135 |
Gamunex 10% |
- |
- |
- |
- |
011 [1] 11 💬 |
136 |
Gamunex-c |
- |
- |
- |
- |
065 [1] 65 💬 |
137 |
Ganaxolone |
Ganaxolone |
[1] D04300 D04300 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
145 [4] 145, 152, 158, 206 💬 |
138 |
Ganaxolone, spt3162, md 9150000, ccd-1042, mepalon 1042, (3a-hydroxy-3beta-methyl-5a-pregnan-20-one) |
Ganaxolone |
[1] D04300 D04300 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
152 [1] 152 💬 |
139 |
Ganaxolone, spt3162, md 9150000, ccd-1042, mepalon 1042, (3a-hydroxy-3ß-methyl-5a-pregnan-20-one) |
Ganaxolone |
[1] D04300 D04300 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
152 [1] 152 💬 |
140 |
Ganciclovir |
Ganciclovir |
[2] D00333 D00333, D04301 D04301 💬 |
- |
- |
028 [3] 28, 60, 97 💬 |
141 |
Ganoderma |
- |
- |
- |
- |
006 [1] 6 💬 |
142 |
Gardasil |
- |
- |
- |
- |
049 [1] 49 💬 |
143 |
Garetosmab |
Garetosmab |
[1] D11443 D11443 💬 |
- |
- |
272 [1] 272 💬 |
144 |
Garlic |
Garlic |
- |
- |
- |
299 [1] 299 💬 |
145 |
Gastro-resistant phosphatidylcholine granules |
Lecithin |
[1] D04682 D04682 💬 |
- |
- |
097 [1] 97 💬 |
146 |
Gastrus |
- |
- |
- |
- |
066 [1] 66 💬 |
147 |
Gentamicin |
Gentamicin |
[2] D01063 D01063, D08013 D08013 💬 |
- |
- |
036 [3] 36, 113, 299 💬 |
148 |
Gentamicin infusions twice a week for six months |
Gentamicin |
[2] D01063 D01063, D08013 D08013 💬 |
- |
- |
113 [1] 113 💬 |
149 |
Gentamicin sulfate |
Gentamicin |
[2] D01063 D01063, D08013 D08013 💬 |
- |
- |
036 [1] 36 💬 |
150 |
Gentamicin sulfate 0.1% ointment |
Gentamicin |
[2] D01063 D01063, D08013 D08013 💬 |
- |
- |
036 [1] 36 💬 |
151 |
Gentamicin sulfate, injectable |
Gentamicin |
[2] D01063 D01063, D08013 D08013 💬 |
- |
- |
036 [1] 36 💬 |
152 |
Glatiramer acetate (ga) |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
153 |
Glatiramer acetate (ga) 40 mg |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
154 |
Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
155 |
Glatiramer acetate [ga] |
Acetate |
[1] D04318 D04318 💬 |
HLA-A [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 [1] 13 💬 |
156 |
Gm1 ganglioside |
- |
- |
- |
- |
006 [1] 6 💬 |
157 |
Helium / oxygen mixed gas inhalation therapy |
Helium |
[2] D00003 D00003, D04420 D04420 💬 |
- |
- |
330 [1] 330 💬 |
158 |
Hpv prophylactic vaccine gardasil |
- |
- |
- |
- |
049 [1] 49 💬 |
159 |
Human papillomavirus vaccination (gardasil) |
- |
- |
- |
- |
049 [1] 49 💬 |
160 |
Human soluble recombinant fc-gamma receptor iib |
- |
- |
- |
- |
066 [1] 66 💬 |
161 |
Humanized immunoglobulin gamma 1 (igg1) kappa monoclonal antibody |
- |
- |
- |
- |
046 [1] 46 💬 |
162 |
Hyperpolarized 129 xenon gas comparing idiopathic pulmonary fibrosis (ipf) treatment |
Xenon |
[2] D01901 D01901, D06339 D06339 💬 |
- |
- |
085 [1] 85 💬 |
163 |
Hyperpolarized 129-xenon gas |
Xenon |
[2] D01901 D01901, D06339 D06339 💬 |
- |
- |
085 [1] 85 💬 |
164 |
Hyperpolarized xenon gas |
Xenon |
[2] D01901 D01901, D06339 D06339 💬 |
- |
- |
299 [1] 299 💬 |
165 |
Ifn-gamma |
- |
- |
- |
- |
065 [1] 65 💬 |
166 |
Inomax 400ppm mol/mol inhalation gas |
- |
- |
- |
- |
085 [2] 85, 299 💬 |
167 |
Interferon gamma |
Interferon Gamma |
- |
- |
- |
018 [8] 18, 65, 85, 107, 228, 299, 301, 326 💬 |
168 |
Interferon gamma 1b |
Interferon Gamma |
- |
- |
- |
228 [1] 228 💬 |
169 |
Interferon gamma-1b |
Interferon Gamma |
[1] D00747 D00747 💬 |
IFNGR1 [2] IFNGR1, IFNGR2 💬 |
Chagas disease [18] Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis |
018 [7] 18, 65, 85, 228, 299, 301, 326 💬 |
170 |
Interferon gamma-1b (actimmune) |
Interferon Gamma |
[1] D00747 D00747 💬 |
IFNGR1 [2] IFNGR1, IFNGR2 💬 |
Chagas disease [18] Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis |
085 [1] 85 💬 |
171 |
Interferon-gamma |
- |
- |
- |
- |
065 [1] 65 💬 |
172 |
Interferon-gamma 1b |
- |
- |
- |
- |
085 [1] 85 💬 |
173 |
Lentivirus alpha-gal a transduced stem cells |
- |
- |
- |
- |
019 [1] 19 💬 |
174 |
Lingzhi (ganoderma) |
- |
- |
- |
- |
006 [1] 6 💬 |
175 |
Liv-gamma sn inj. |
- |
- |
- |
- |
063 [1] 63 💬 |
176 |
Mesalazine 1000 mg gastro-resistant tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
177 |
Mesalazine 500 mg gastro-resistant tablets (salofa |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
178 |
Mesalazine 500 mg gastro-resistant tablets (salofalk® 500 mg) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
179 |
Metalcaptase® 150 mg gastro-resistant tablet |
- |
- |
- |
- |
171 [1] 171 💬 |
180 |
Metalcaptase® 300 mg gastro-resistant tablet |
- |
- |
- |
- |
171 [1] 171 💬 |
181 |
Mezavant gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
182 |
Mezavant xl 1200 mg gastro-resistant prolonged release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
183 |
Mezavant xl 1200 mg gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
184 |
Mezavant xl 1200 mg gastro-resistant, prolonged release tablets. |
- |
- |
- |
- |
097 [1] 97 💬 |
185 |
Mezavant xl 1200mg gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
186 |
Mezavant xl gastro-resistant, prolonged release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
187 |
Moss-agal (recombinant human alpha-galactosidase a produced in moss) |
Agalsidase alfa |
[1] D02784 D02784 💬 |
GLA [1] GLA 💬 |
Galactose metabolism [6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 [1] 19 💬 |
188 |
Multi-modal pain management [acetaminophen + gabapentin] |
Acetaminophen |
[2] D00217 D00217, D00332 D00332 💬 |
CACNA2D1 [7] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, PTGS1, PTGS2, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [31] Adrenergic signaling in cardiomyocytes, Alzheimer disease, Arachidonic acid metabolism, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cardiac muscle contraction, Chemical carcinogenesis, Dilated cardiomyopathy, GABAergic synapse, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MAPK signaling pathway, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Synaptic vesicle cycle, TNF signaling pathway, VEGF signaling pathway |
070 [1] 70 💬 |
189 |
Multi-modal pain management [valium + gabapentin] |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
070 [1] 70 💬 |
190 |
Naglazyme (galsulfase) |
Galsulfase |
[1] D06565 D06565 💬 |
ARSB [1] ARSB 💬 |
Glycosaminoglycan degradation [3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 [1] 19 💬 |
191 |
Neo-gaa |
- |
- |
- |
- |
256 [1] 256 💬 |
192 |
Noxafil gastro resistant tablets |
- |
- |
- |
- |
060 [1] 60 💬 |
193 |
Obinutuzumab |
Obinutuzumab |
[1] D09321 D09321 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
222 [1] 222 💬 |
194 |
Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (arterial blood gas and metabolic panel) and data collection from psg study. |
- |
- |
- |
- |
230 [1] 230 💬 |
195 |
Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (venous blood gas and metabolic panel) and data collection from psg study. |
- |
- |
- |
- |
230 [1] 230 💬 |
196 |
Other: computer game based balance and walking rehabilitation for individuals with parkinson's disease |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
197 |
Other: gadobutrol |
Gadobutrol |
[1] D07420 D07420 💬 |
- |
- |
046 [1] 46 💬 |
198 |
Other: gait and balance group training |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
199 |
Other: transthoracic echocardiography at rest, during plr, hg and cpx (including blood gas analysis in both groups). additionally fallot patients will undergo routine blood testings. |
- |
- |
- |
- |
215 [1] 215 💬 |
200 |
Other: uspio mri - gadolinium mri |
Gadolinium |
- |
- |
- |
013 [1] 13 💬 |
201 |
Ov101 (gaboxadol) |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
206 [1] 206 💬 |
202 |
Pantoprazolo 20 mg gastro-resistant tablets |
- |
- |
- |
- |
065 [1] 65 💬 |
203 |
Perfluorinated gas/oxygen mixture |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
299 [1] 299 💬 |
204 |
Prednisolone 5mg gastro-resistant tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
205 |
Prefolic*30cpr gastror 15mg |
- |
- |
- |
- |
299 [1] 299 💬 |
206 |
Procedure: gastrointestinal evaluation |
- |
- |
- |
- |
078 [1] 78 💬 |
207 |
Procedure: gastroscopy |
- |
- |
- |
- |
097 [1] 97 💬 |
208 |
Procedure: mri imaging with intravenous contrast with gadoterate meglumine |
Gadoteric acid |
[2] D01796 D01796, D08007 D08007 💬 |
- |
- |
053 [1] 53 💬 |
209 |
Procedure: no gas |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
210 |
Procedure: percutaneous endoscopic gastrostomy with jejunal extension (peg-j) |
- |
- |
- |
- |
006 [1] 6 💬 |
211 |
Procedure: physiotherapy, exercise, percutaneous gastrostomy feeds |
- |
- |
- |
- |
299 [1] 299 💬 |
212 |
Prohance (gadoteridol) |
Gadoteridol |
[1] D01137 D01137 💬 |
- |
- |
013 [1] 13 💬 |
213 |
Raav-gad |
- |
- |
- |
- |
006 [1] 6 💬 |
214 |
Raav1-cmv-gaa (study agent) administration |
- |
- |
- |
- |
256 [1] 256 💬 |
215 |
Raavrh74.mck.galgt2 |
- |
- |
- |
- |
113 [1] 113 💬 |
216 |
Radiation: gadopentetate dimeglumine |
Gadopentetic acid |
[2] D01707 D01707, D08006 D08006 💬 |
- |
- |
013 [2] 13, 34 💬 |
217 |
Recombinant adeno-associated virus 2/6 vector encoding the cdna for human alpha galactosidase a |
- |
- |
- |
- |
019 [1] 19 💬 |
218 |
Recombinant alpha-galactosidase a |
Agalsidase alfa |
[1] D02784 D02784 💬 |
GLA [1] GLA 💬 |
Galactose metabolism [6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 [1] 19 💬 |
219 |
Recombinant human alpha-galactosidase |
- |
- |
- |
- |
019 [1] 19 💬 |
220 |
Recombinant human alpha-galactosidase abbreviated as r-h-alpha-gal |
- |
- |
- |
- |
019 [1] 19 💬 |
221 |
Recombinant human growth hormone + rosiglitazone |
Rosiglitazone |
[3] D00596 D00596, D02691 D02691, D08491 D08491 💬 |
GHR [2] GHR, PPARG 💬 |
AMPK signaling pathway [14] AMPK signaling pathway, Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Huntington disease, JAK-STAT signaling pathway, Longevity regulating pathway, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
265 [1] 265 💬 |
222 |
Retinoic acid receptor gamma agonist |
Tretinoin |
[1] D00094 D00094 💬 |
PML [3] PML, RARA, RARB 💬 |
Acute myeloid leukemia [12] Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis |
231 [1] 231 💬 |
223 |
Rosiglitazone |
Rosiglitazone |
[2] D00596 D00596, D08491 D08491 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 [5] 46, 75, 97, 222, 265 💬 |
224 |
Rosiglitazone (avandia) |
Rosiglitazone |
[2] D00596 D00596, D08491 D08491 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
222 [1] 222 💬 |
225 |
Rosiglitazone extended release tablets |
Rosiglitazone |
[2] D00596 D00596, D08491 D08491 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 [1] 46 💬 |
226 |
Rosiglitazone maleate |
Rosiglitazone |
[2] D00596 D00596, D08491 D08491 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 [3] 46, 75, 265 💬 |
227 |
Rosiglitazone xr |
Rosiglitazone |
[2] D00596 D00596, D08491 D08491 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
046 [1] 46 💬 |
228 |
Rs-baclofen |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
010 [1] 10 💬 |
229 |
Salofalk 3g gastro-resistant prolonged-release granules |
- |
- |
- |
- |
097 [1] 97 💬 |
230 |
Salofalk® 500 mg gastro-resistant tablet |
- |
- |
- |
- |
097 [1] 97 💬 |
231 |
Simethicone |
Simethicone |
[1] D05841 D05841 💬 |
- |
- |
013 [2] 13, 96 💬 |
232 |
Sodium valproate 200 mg gastro-resistant tablets |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
233 [1] 233 💬 |
233 |
Sodium valproate wockhardt 200mg gastro-resistant tablets |
Valproic acid |
[1] D00399 D00399 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
233 [1] 233 💬 |
234 |
Soluble fc-gamma receptor iib |
- |
- |
- |
- |
049 [1] 49 💬 |
235 |
Standard gadolinium contrast |
Gadolinium |
- |
- |
- |
013 [1] 13 💬 |
236 |
Sulfamethoxazole |
Sulfamethoxazole |
[1] D00447 D00447 💬 |
- |
- |
044 [4] 44, 49, 85, 299 💬 |
237 |
Tcm (gan-lu-yin)gly |
- |
- |
- |
- |
053 [1] 53 💬 |
238 |
Teduglutide |
Teduglutide |
[1] D06053 D06053 💬 |
GLP2R [1] GLP2R 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
239 |
Teduglutide (alx-0600) |
Teduglutide |
[1] D06053 D06053 💬 |
GLP2R [1] GLP2R 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
240 |
Teduglutide 0.05 |
Teduglutide |
[1] D06053 D06053 💬 |
GLP2R [1] GLP2R 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
241 |
Teduglutide 0.05 dose |
Teduglutide |
[1] D06053 D06053 💬 |
GLP2R [1] GLP2R 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
242 |
Teduglutide 0.1 mg dose |
Teduglutide |
[1] D06053 D06053 💬 |
GLP2R [1] GLP2R 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
243 |
Teduglutide 0.2 mg |
Teduglutide |
[1] D06053 D06053 💬 |
GLP2R [1] GLP2R 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
244 |
Transdermal fentanyl matrix, gabapentin |
Fentanyl |
[3] D00320 D00320, D00332 D00332, D01399 D01399 💬 |
CACNA2D1 [6] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, OPRM1, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [12] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Estrogen signaling pathway, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Synaptic vesicle cycle |
070 [1] 70 💬 |
245 |
Trimethoprim and sulfamethoxazole |
Sulfamethoxazole |
[3] D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
299 [1] 299 💬 |
246 |
Trimethoprim sulfamethoxazole |
Sulfamethoxazole |
[3] D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
044 [1] 44 💬 |
247 |
Trimethoprim sulfamethoxazole (tmp/smx) |
Sulfamethoxazole |
[3] D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
299 [1] 299 💬 |
248 |
Trimethoprim-sulfamethoxazole |
Sulfamethoxazole |
[3] D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
049 [2] 49, 299 💬 |
249 |
Trimethoprim/sulfamethoxazole |
Sulfamethoxazole |
[3] D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
299 [1] 299 💬 |
250 |
Trimethoprim/sulfamethoxazole (tmp/smx) |
Sulfamethoxazole |
[3] D00145 D00145, D00447 D00447, D06236 D06236 💬 |
- |
- |
299 [1] 299 💬 |
251 |
Zinc acetate |
Acetate |
[1] D06408 D06408 💬 |
- |
- |
171 [2] 171, 299 💬 |
252 |
Zinc acetate (20mg/d) |
Acetate |
[1] D06408 D06408 💬 |
- |
- |
299 [1] 299 💬 |
253 |
Zinc acetate dihydrate |
Acetate |
[1] D06408 D06408 💬 |
- |
- |
171 [1] 171 💬 |
254 |
Ácido gadobénico |
- |
- |
- |
- |
096 [1] 96 💬 |